| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 7, 2026 | ±3.1% | +9.0% | under-priced |
| November 6, 2025 | ±2.5% | -6.0% | under-priced |
| August 7, 2025 | ±2.7% | +7.3% | under-priced |
| May 8, 2025 | ±3.2% | +5.7% | under-priced |
| November 7, 2024 | ±2.6% | +13.5% | under-priced |
| August 8, 2024 | ±3.1% | +6.5% | under-priced |
| May 9, 2024 | ±2.0% | -5.0% | under-priced |
| November 8, 2023 | ±2.1% | +1.0% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.15 | $3.5B | $176M |
| Q4 FY2025 | $-0.30 | $3.7B | $-340M |
| Q3 FY2025 | $-0.11 | $3.8B | $-128M |
| Q2 FY2025 | — | $3.6B | $-5M |
Viatris Inc. Common Stock (VTRS) reports in 99 days, with the next report estimated for September 20, 2026. Across the last 8 reports, options priced an average ±2.6% earnings move while the stock actually moved 6.8% on average — the market has tended to under-price VTRS's earnings risk. Fundamentals into the print: EPS up 105.9% year-over-year, revenue up 8.1%. QuantLogix's live 5-factor engine currently reads VTRS as a buy at 56/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →